Literature DB >> 21472632

Aerobic exercise as a therapy option for migraine: a pilot study.

S Darabaneanu1, C H Overath, D Rubin, S Lüthje, W Sye, U Niederberger, W-D Gerber, B Weisser.   

Abstract

Exercise is assumed to have a positive effect on migraine. However, none of the few studies on this topic can prove the expected positive influence of exercise. Therefore, the aim of this pilot study was to develop a training program suitable for migraine patients and to examine its effect on migraine. 16 patients were examined. 8 migraine patients completed a 10-week aerobic running exercise program consisting of 3 workouts per week. The program was developed by sports scientists especially to increase the fitness level. Physical fitness, i. e., physical working capacity, was assessed using a PWC 150 test. There was also a control group of 8 patients without any special physical training. Migraine patients of the exercise group showed both a reduction in the number of migraine days per month (p=0.048) and the intensity of the attacks (p=0.028). An increase in fitness level resulted in a lowered stress level. Stress strategies like "displacement activity" (r=-0.715; p=0.046), "looking for self-affirmation" (r=-0.742; p=0.035) and "feelings of aggression" (r=-0.802; p=0.017) were reduced. Increasing the level of fitness (PWC 150) is one predictor for migraine improvement (r=0.409, p=0.031). Aerobic exercise which leads to a better fitness level is an alternative therapy method for migraine. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21472632     DOI: 10.1055/s-0030-1269928

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  30 in total

1.  The association of obesity with episodic and chronic migraine.

Authors:  Randolph W Evans; Michelle A Williams; Alan M Rapoport; B Lee Peterlin
Journal:  Headache       Date:  2012-03-08       Impact factor: 5.887

2.  Anandamide Is Related to Clinical and Cardiorespiratory Benefits of Aerobic Exercise Training in Migraine Patients: A Randomized Controlled Clinical Trial.

Authors:  Arão Belitardo Oliveira; Reinaldo Teixeira Ribeiro; Marco Tulio Mello; Sergio Tufik; Mario Fernando Prieto Peres
Journal:  Cannabis Cannabinoid Res       Date:  2019-12-09

3.  Intranasally administered IGF-1 inhibits spreading depression in vivo.

Authors:  Yelena Y Grinberg; Lois A Zitzow; Richard P Kraig
Journal:  Brain Res       Date:  2017-09-23       Impact factor: 3.252

4.  [Relaxation techniques and behavioural therapy for the treatment of migraine : Guidelines from the German Migraine and Headache Society].

Authors:  P Kropp; B Meyer; T Dresler; G Fritsche; C Gaul; U Niederberger; S Förderreuther; V Malzacher; T P Jürgens; M Marziniak; A Straube
Journal:  Schmerz       Date:  2017-10       Impact factor: 1.107

Review 5.  Current Treatment Options: Headache Related to Menopause-Diagnosis and Management.

Authors:  Clinton G Lauritsen; Abigail L Chua; Stephanie J Nahas
Journal:  Curr Treat Options Neurol       Date:  2018-03-06       Impact factor: 3.598

Review 6.  Headache in sports.

Authors:  Tad Seifert
Journal:  Curr Pain Headache Rep       Date:  2014-09

7.  Migraine and obesity: moving beyond BMI.

Authors:  Ana Recober; B Lee Peterlin
Journal:  Future Neurol       Date:  2014-01-01

8.  The effects of two different intensities of aerobic training protocols on pain and serum neuro-biomarkers in women migraineurs: a randomized controlled trail.

Authors:  Rasoul Eslami; Abdolhossein Parnow; Zahra Pairo; Pantelis Nikolaidis; Beat Knechtle
Journal:  Eur J Appl Physiol       Date:  2020-11-18       Impact factor: 3.078

Review 9.  Post-Traumatic Headache Therapy in the Athlete.

Authors:  Tad Seifert
Journal:  Curr Pain Headache Rep       Date:  2016-06

10.  Environmental Enrichment Stimulates Immune Cell Secretion of Exosomes that Promote CNS Myelination and May Regulate Inflammation.

Authors:  Kae M Pusic; Aya D Pusic; Richard P Kraig
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.